XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   103,229,013    
Beginning balance at Dec. 31, 2022 $ 116,928 $ 10 $ 543,456 $ (426,538)
Equity        
Proceeds from the exercise of stock options (in shares)   100,158    
Proceeds from the exercise of stock options 119   119  
Stock-based compensation 1,809   1,809  
Net income (loss) (36,969)     (36,969)
Ending balance (in shares) at Mar. 31, 2023   103,329,171    
Ending balance at Mar. 31, 2023 81,887 $ 10 545,384 (463,507)
Beginning balance (in shares) at Dec. 31, 2022   103,229,013    
Beginning balance at Dec. 31, 2022 116,928 $ 10 543,456 (426,538)
Equity        
Net income (loss) (59,675)      
Ending balance (in shares) at Jun. 30, 2023   103,408,248    
Ending balance at Jun. 30, 2023 61,117 $ 10 547,320 (486,213)
Beginning balance (in shares) at Mar. 31, 2023   103,329,171    
Beginning balance at Mar. 31, 2023 81,887 $ 10 545,384 (463,507)
Equity        
Proceeds from the exercise of stock options (in shares)   79,077    
Proceeds from the exercise of stock options 95   95  
Stock-based compensation 1,841   1,841  
Net income (loss) (22,706)     (22,706)
Ending balance (in shares) at Jun. 30, 2023   103,408,248    
Ending balance at Jun. 30, 2023 $ 61,117 $ 10 547,320 (486,213)
Beginning balance (in shares) at Dec. 31, 2023 103,673,728 103,673,728    
Beginning balance at Dec. 31, 2023 $ 13,546 $ 10 550,850 (537,314)
Equity        
Issuance of stock in public offering, net of issuance costs (in shares)   15,410,000    
Issuance of stock in public offering, net of issuance costs 43,046 $ 2 43,044  
Proceeds from the exercise of stock options (in shares)   625    
Proceeds from the exercise of stock options 2   2  
Stock-based compensation 1,454   1,454  
Net income (loss) (31,896)     (31,896)
Ending balance (in shares) at Mar. 31, 2024   119,084,353    
Ending balance at Mar. 31, 2024 $ 26,152 $ 12 595,350 (569,210)
Beginning balance (in shares) at Dec. 31, 2023 103,673,728 103,673,728    
Beginning balance at Dec. 31, 2023 $ 13,546 $ 10 550,850 (537,314)
Equity        
Proceeds from the exercise of stock options (in shares) 263,960      
Net income (loss) $ (88,559)      
Ending balance (in shares) at Jun. 30, 2024 119,347,688 119,347,688    
Ending balance at Jun. 30, 2024 $ (28,287) $ 12 597,574 (625,873)
Beginning balance (in shares) at Mar. 31, 2024   119,084,353    
Beginning balance at Mar. 31, 2024 26,152 $ 12 595,350 (569,210)
Equity        
Proceeds from the exercise of stock options (in shares)   263,335    
Proceeds from the exercise of stock options 787   787  
Stock-based compensation 1,437   1,437  
Net income (loss) $ (56,663)     (56,663)
Ending balance (in shares) at Jun. 30, 2024 119,347,688 119,347,688    
Ending balance at Jun. 30, 2024 $ (28,287) $ 12 $ 597,574 $ (625,873)